Repligen Corporation (RGEN)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$177.46
-0.41%
Mkt Cap $9.32B
Analyst Ratings
Buy
11
Hold
1
Sell
0
Price Target (24 analysts)
$158.86
Range $142.00 – $200.00
Implied Upside
-10.5%
Consensus $158.86 vs current $177.46